Back to search

Article

Clonazepam repurposing in ARID1B patients through conventional RCT and N-of-1 Trials - An experimental strategy for orphan disease development

2024-02-12

Abstract excerpt

<h4>Background: </h4> Clinical trials for rare disorders have unique challenges, due to low prevalence, patient phenotype variability, and high expectations. These challenges are highlighted by our study on clonazepam in ARID1B patients, a common cause of intellectual disability. Previous studies on Arid1b haploinsufficient mice showed positive effects of clonazepam on various cognitive aspects. <h4>Methods: </h4...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0fc29e3c-d9c5-5f97-8ff1-426900559abd
DOI
10.21203/rs.3.rs-3937179/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clonazepam repurposing in ARID1B patients through conventional RCT and N-of-1 Trials - An experimental strategy for orphan disease developmentDOI 10.21203/rs.3.rs-3937179/v1
Select a neighboring publication to make it the new centre.